VERASTEM, INC.
🏢 View company profile →12Patents
12Active
12Granted
50Portfolio score
Filing activity: Nov 20, 2006 → Dec 29, 2022 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8247410B2 | Pyrimidine substituted purine derivatives | Chemistry; Metallurgy | 3 | Active |
| US10406158B2 | Methods and compositions for treating abnormal cell growth | Human Necessities | 3 | Active |
| US9962385B2 | Methods and compositions for treating abnormal cell growth | Human Necessities | 3 | Active |
| US8609838B2 | Pyrimidine substituted purine derivatives | Chemistry; Metallurgy | 3 | Active |
| US10532056B2 | Therapeutic compositions, combinations, and methods of use | Chemistry; Metallurgy | 3 | Active |
| US8754080B2 | Pyrimidine substituted purine compounds as kinase (S) inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11564927B2 | Therapeutic compositions, combinations, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US9138437B2 | Pyrimidine substituted purine compounds as kinase (S) inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9375402B2 | Oral formulations of kinase inhibitors | Human Necessities | 0 | Active |
| US8722884B2 | Pyrimidine derivatives for the treatment of abnormal cell growth | Human Necessities | 0 | Active |
| US9505719B2 | Synthesis and use of kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11873296B2 | Solid forms of a dual RAF/MEK inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.